KB Medical Group Inc. is a professional company specialized in producing innovative Safety Medical Products to protect health care workers against sharps injury. The company's commitment lies in providing the most effective safety-engineered therapy devices for optimum safety in hospitals. Founded in 1986 and headquartered in the United States, KB Medical Group has been focused on developing a wide variety of innovative, high-quality enteral feeding products and accessories. Their new standard ENFit™ connection, in-line with ISO80369-3, is uniquely designed to reduce the risk of enteral tube feeding misconnections, thus improving patient safety.
In addition to nutrition therapy, the company also offers various other medical categories including infusion therapy, syringe and needle products, hazardous drug safety, specimen collection, anesthesia and pain management, transfusion therapy, urinary care, renal therapy, and diabetes care.
KB Medical Group Inc. presents a compelling opportunity for investors as it operates in the Health Care and Manufacturing industries. While the specific details of its last investment and associated investors are not available, the company's focus on addressing critical safety issues in healthcare and its track record of innovation make it an intriguing prospect for potential funding opportunities and partnerships.